DiabetesMine: I cant wait to get my next A1C test done (who says that?! but its true). I am now two-plus months into my use of new inhaled insulinAfrezza, and frankly Im blown away by how well it performs (ooh, pun!) Ive been hesitant to be too much of a cheerleader for Afrezza, because I […]
Category: The issues (Page 2)
Washington, D.C., April 15, 2015 The U.S. Senate overwhelmingly approved legislation last night for a two-year extension of the Special Diabetes Program (SDP)an initiative that accounts for roughly one-third of all Federally-funded type 1 diabetes (T1D) research in the United States. The decision comes on the heels of the strong bipartisan approval of the legislation […]
ARMONK, NY and DUBLIN April 13, 2015IBM (NYSE:IBM) andMedtronic(NYSE: MDT) today announced that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions. People using Medtronic diabetes solutions could benefit from new solutions developed in collaboration with […]
MedPage Today WASHINGTON The current trend toward steeply rising prices for specialty drugs should not be allowed to continue, several experts said Thursday. We are willing to pay more to get more but were probably not willing to pay more each for benefits that are smaller each time,Peter Bach, MD, director of the Center for […]
Now People With Diabetes and Caregivers Have Access to Life-Saving Glucose Data in a Convenient and Discreet Manner Right from their Wrist SAN DIEGO(BUSINESS WIRE)Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that its Dexcom G4 PLATINUM Continuous Glucose Monitor System with Share will support the Apple […]
Three-year grant includes 2:1 matching program that could yield $1.25 million in new donations The Leona M. and Harry B. Helmsley Charitable Trusthas awardedUnitio$8.7 million to extend the reach and impact ofT1D Exchange, a nonprofit dedicated to mitigating barriers to research and improving outcomes for people living with type 1 diabetes (T1D). The three-year grant […]
From: http://www.marketwatch.com/story/dreamed-diabetes-and-medtronic-enter-strategic-collaboration-2015-04-06 DreaMed Diabetes licenses artificial pancreas technology for integration into future Medtronic insulin pumps Medtronic invests $2 million in DreaMed Diabetes PETAH TIKVA, Israel, Apr 06, 2015 (BUSINESS WIRE) DreaMed Diabetes, developer of diabetes treatment and management solutions, announced today that it had signed an exclusive worldwide development and license agreement with Medtronic,theworldspremiermedical technologyand […]
April 7, 2015 | 1 to 2 p.m. Eastern | Webinar Since the Patient-Focused Drug Development (PFDD) initiative was launched in 2012, the Food andDrug Administration (FDA) has held or scheduled 14 disease-specific meetings to better understand patients experience with symptoms, impacts on daily living, and available therapies. With more meetings on the docket for […]
From:http://diatribe.org/jama-paper-breaks-down-medical-research-funding-us The Journal of the American Medical Association (JAMA) recently published a Special Communication paper titled The Anatomy of Medical Research, analyzing medical research funding worldwide between 1994 and 2012. The paper is one of the first and largest of its kind to examine medical research spending on a global scale, and its results identify […]
SourceDHF Blog:http://diabeteshandsfoundation.org/dhf-joins-diabetes-advocacy-alliance/ Diabetes Hands Foundation is incredibly honored to join theDiabetes Advocacy Alliance, an organization with the drive and potential to affect a powerful, positive impact on diabetes and healthcare policy. Diabetes Advocacy Alliance is a 20-member coalition of leading professional societies, nonprofit organizations, and policy change-makers from across the national diabetes landscape. Included among […]